2021
DOI: 10.1038/s41598-021-96162-5
|View full text |Cite
|
Sign up to set email alerts
|

Clinical outcomes of frozen autograft reconstruction for the treatment of primary bone sarcoma in adolescents and young adults

Abstract: Age affects the clinical outcomes of cancer treatment, including those for bone sarcoma. Successful reconstruction using frozen autograft after excision of bone sarcoma has been reported; however, little is known about the clinical outcomes of frozen autograft reconstruction according to age. The purpose was to evaluate the clinical outcomes of the frozen autograft reconstruction focusing on skeletally mature adolescents and young adults (AYAs) that was 15 to 39 years of age. A total of 37 AYA patients with pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
10
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 47 publications
1
10
1
Order By: Relevance
“…Tumor-devitalized autograft reconstruction is a unique biological procedure involving reimplantation of tumor-bearing bone after the following devitalized treatment: extracorporeal irradiation [45][46][47][48][49][50][51], pasteurization [52][53][54][55][56][57], and freezing [58][59][60][61][62][63][64][65][66]. The advantages of the autograft include a perfect fit to the original site, no risk of viral transmission or immune response problems, easy attachment of capsules, ligaments and tendons, preservation of bone stock, biological stability after graft union, and absence of donor-site morbidity.…”
Section: Tumor-devitalized Autograft Reconstructionmentioning
confidence: 99%
See 2 more Smart Citations
“…Tumor-devitalized autograft reconstruction is a unique biological procedure involving reimplantation of tumor-bearing bone after the following devitalized treatment: extracorporeal irradiation [45][46][47][48][49][50][51], pasteurization [52][53][54][55][56][57], and freezing [58][59][60][61][62][63][64][65][66]. The advantages of the autograft include a perfect fit to the original site, no risk of viral transmission or immune response problems, easy attachment of capsules, ligaments and tendons, preservation of bone stock, biological stability after graft union, and absence of donor-site morbidity.…”
Section: Tumor-devitalized Autograft Reconstructionmentioning
confidence: 99%
“… Femur (46), Tibia (14) Humerus (4) OS(79) 82 ± 54 months 83%/5 years Wound complication(6), Nonunion(8), Fracture(2), Implant failure(1), Infection(6) n.a Lee SY, 2018 [ 53 ] Pasteurized 278 24 (5–72) n.a. Femur(137), Tibia(81) Humerus(34) OS(201), ES(11), CS(23) 113 months (25–295) 59%/10 years 40%/20 years Infecction13%, Nonunion7%, Fracture6%, Bone absorption6% n.a Ikuta K, 2018 [ 55 ] Pasteurized 24 22 (5–61) 5 Femur(17), Tibia(1) Humerus(4) OS(20) 88 months (28–208) 70.1%/5 years 70.1%/10 years Nonunion(14), Infection(3), Bone absorption(5), fracture(1) 76% Sugiura H, 2012 [ 54 ] Pasteurized 46 30.7 (10–78) 30 Femur(15), Tibia(10), Humerus(2) OS(17), ES(3), CS(5), 8.7 years (2–17) 94%/10 years Nonunion17%, Fracture15%, Infection13%, Bone absorption13% 83.8% Araki Y, 2021 [ 65 ] Frozen 37 23 (15–39) 37 Femur(20), Tibia(11), Humerus(5), Calcaneus(1) OS(29), ES(3), UPS(3) 89 months (5–229) 86%/5 years, 76%/10 years Infection(7),OA(5), Bone absorption(3), Fracture(2), Nonunion(1), Deformity(1) Excellent 79% Wu PK, 2018 [ 49 …”
Section: Tumor-devitalized Autograft Reconstructionmentioning
confidence: 99%
See 1 more Smart Citation
“…The incidence of SSI in total hip arthroplasty was reported as 0.2% [ 13 ], whereas the incidences of SSI in spine surgeries were reported as 3.4–4.2% [ 10 , 12 ]. On the other hand, high incidences of SSI have been reported in patients with malignant bone tumors [ 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 ]. In patients who underwent megaprosthesis after malignant bone tumor resection, 9.3–20.4% of the patients had SSI [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…In patients who underwent megaprosthesis after malignant bone tumor resection, 9.3–20.4% of the patients had SSI [ 14 , 15 ]. SSI rates after biological reconstruction were reported as 11.9–13.5% [ 16 , 17 ]. In patients with SSI, additional treatments (such as the long-term administration of antibiotics, implant and grafted bone removal, debridement, irrigation, and reconstruction) are often required.…”
Section: Introductionmentioning
confidence: 99%